Literature DB >> 8584456

Inhibition of oncogene expression by green tea and (-)-epigallocatechin gallate in mice.

G Hu1, C Han, J Chen.   

Abstract

The effects of tea drinking on the tobacco-specific nitrosamine 4-(methylnitrosamine)-1-(3-pyridyl)-1-butanone (NNK)-induced mouse lung oncogene expression and the effect of topical application of the tea polyphenol component (-)-epigallocatechin-3-gallate (EGCG) on 12-O-tedradecanoylphorbol-13-acetate (TPA)-induced mouse skin oncogene expression were investigated. In the first experiment, mice were treated with NNK (1.3 mg/kg body wt ip) once a day for three days and were given 2% tea in drinking water during the whole experimental period. After four or eight weeks, the lung tissue of the mice treated with NNK displayed a significantly high level of expression in c-myc, c-raf, and c-H-ras oncogenes, and they were all inhibited by tea drinking with inhibitory rates of 50%, 20%, and 50%, respectively. In the second experiment, a single application of 10 nmol of TPA to mouse skin led to a marked increase in the transcripts' level of ornithine decarboxylase (ODC) gene, protein kinase C (PKC) gene, and c-myc oncogene at four hours after TPA administration. Topical application of EGCG (1 or 5 mumol) one hour before the application of TPA inhibited all TPA-induced gene expression in a dose-dependent fashion. These results confirm the anticarcinogenic effects of tea and suggest that a possible mechanism is the effect of tea on carcinogen-induced oncogene expression.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584456     DOI: 10.1080/01635589509514408

Source DB:  PubMed          Journal:  Nutr Cancer        ISSN: 0163-5581            Impact factor:   2.900


  4 in total

1.  Epigallocatechin-3-gallate augments the therapeutic effects of benzo[a]pyrene-mediated lung carcinogenesis.

Authors:  Meghan M Cromie; Zhongwei Liu; Weimin Gao
Journal:  Biofactors       Date:  2017-03-01       Impact factor: 6.113

2.  A Phase II Randomized, Double-blind, Presurgical Trial of Polyphenon E in Bladder Cancer Patients to Evaluate Pharmacodynamics and Bladder Tissue Biomarkers.

Authors:  Jason R Gee; Daniel R Saltzstein; KyungMann Kim; Jill Kolesar; Wei Huang; Thomas C Havighurst; Barbara W Wollmer; Jeanne Stublaski; Tracy Downs; Hasan Mukhtar; Margaret G House; Howard L Parnes; Howard H Bailey
Journal:  Cancer Prev Res (Phila)       Date:  2017-03-21

Review 3.  EGCG, green tea polyphenols and their synthetic analogs and prodrugs for human cancer prevention and treatment.

Authors:  Di Chen; Sheng Biao Wan; Huanjie Yang; Jian Yuan; Tak Hang Chan; Q Ping Dou
Journal:  Adv Clin Chem       Date:  2011       Impact factor: 5.394

Review 4.  Implications of Green Tea and Its Constituents in the Prevention of Cancer via the Modulation of Cell Signalling Pathway.

Authors:  Arshad H Rahmani; Fahad M Al Shabrmi; Khaled S Allemailem; Salah M Aly; Masood A Khan
Journal:  Biomed Res Int       Date:  2015-04-21       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.